G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease. - Signoretti C; Matsumura S; Fatehi S; D'Silva M; Mathew R; Cendali F; D'Alessandro A; Alam SMS; Garcia V; Miano JM; Gupte SA (Journal of the American Heart Association, 2024)